EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
40 hedge funds and large institutions have $366M invested in Evelo Biosciences, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+3
Holders Change %
+8.11%
% of All Funds
0.89%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
6
Increased
21
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
+$5.34M |
2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.79M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$964K |
4 |
State Street
Boston,
Massachusetts
|
+$924K |
5 |
Northern Trust
Chicago,
Illinois
|
+$908K |
Top Sellers
1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$2.88M |
2 |
Goldman Sachs
New York
|
-$370K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$24.1K |
4 |
Barclays
London,
United Kingdom
|
-$24K |
5 |
Victory Capital Management
San Antonio,
Texas
|
-$19.8K |